A
Andrew J. Stephenson
Researcher at Cleveland Clinic
Publications - 269
Citations - 12981
Andrew J. Stephenson is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 51, co-authored 260 publications receiving 11679 citations. Previous affiliations of Andrew J. Stephenson include McGill University & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson,Peter T. Scardino,Michael W. Kattan,Thomas M. Pisansky,Kevin M. Slawin,Eric A. Klein,Mitchell S. Anscher,Jeff M. Michalski,Howard M. Sandler,Daniel W. Lin,Jeffrey D. Forman,Michael J. Zelefsky,Larry L. Kestin,Claus G. Roehrborn,Charles Catton,Theodore L. DeWeese,Stanley L. Liauw,Richard K. Valicenti,Deborah A. Kuban,Alan Pollack +19 more
TL;DR: Nearly half of patients with recurrent prostate cancer after radical prostatectomy have a long-term PSA response to SRT when treatment is administered at the earliest sign of recurrence, which should prove valuable for medical decision making for patients with a rising PSA level.
Journal ArticleDOI
Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy
Andrew J. Stephenson,Peter T. Scardino,James A. Eastham,Fernando J. Bianco,Zohar A. Dotan,Paul A. Fearn,Michael W. Kattan +6 more
TL;DR: A new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy, and adds the prognostic information of systematic biopsy results, and enabled the predictions to be adjusted for the year of surgery.
Journal ArticleDOI
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
Andrew J. Stephenson,Peter T. Scardino,James A. Eastham,Fernando J. Bianco,Zohar A. Dotan,Christopher J. DiBlasio,Alwyn M. Reuther,Eric A. Klein,Michael W. Kattan +8 more
TL;DR: This work has developed and validated as a robust predictive model an enhanced postoperative nomogram for prostate cancer recurrence after radical prostatectomy (RP), which can be adjusted for the disease-free interval that a patient has achieved after RP.
Journal ArticleDOI
Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson,Shahrokh F. Shariat,Michael J. Zelefsky,Michael W. Kattan,E. Brian Butler,Bin S. Teh,Eric A. Klein,Patrick A. Kupelian,Claus G. Roehrborn,David A. Pistenmaa,Heather D. Pacholke,Stanley L. Liauw,Matthew S. Katz,Steven A. Leibel,Peter T. Scardino,Kevin M. Slawin,Kevin M. Slawin +16 more
TL;DR: Gleason score, preradiotherapy PSA level, surgical margins, PSADT, and seminal vesicle invasion are prognostic variables for a durable response to salvage radiotherapy.
Journal ArticleDOI
Gene expression profiling predicts clinical outcome of prostate cancer.
Gennadi V. Glinsky,Anna B. Glinskii,Andrew J. Stephenson,Robert M. Hoffman,William L. Gerald +4 more
TL;DR: A gene expression-based recurrence predictor algorithm was informative in predicting the outcome in patients with early-stage disease, with either high or low preoperative prostate-specific antigen levels and provided additional value to the outcome prediction based on Gleason sum or multiparameter nomogram.